Abstract: During the past decades, numerous achievements concerning luminescent zinc oxide nanoparticles (ZnO NPs) have been reported due to their improved luminescence and good biocompatibility. The photoluminescence of ZnO NPs usually contains two parts, the exciton-related ultraviolet (UV) emission and the defect-related visible emission. With respect to the visible emission, many routes have been developed to synthesize and functionalize ZnO NPs for the applications in detecting metal ions and biomolecules, biological fluorescence imaging, nonlinear multiphoton imaging, and fluorescence lifetime imaging. As the biological applications of ZnO NPs develop rapidly, the toxicity of ZnO NPs has attracted more and more attention because ZnO can produce the reactive oxygen species (ROS) and release Zn 2+ ions. Just as a coin has two sides, both the drug delivery and the antibacterial effects of ZnO NPs become attractive at the same time. Hence, in this review, we will focus on the progress in the synthetic methods, luminescent properties, and biological applications of ZnO NPs.
Introduction
Luminescent nanomaterials with potential biological applications have received extensive attention during the past years [1, 2] . Previously, semiconductor quantum dots (QDs) were the most investigated luminescent nanomaterials, owing to their advantages over the organic dyes and fluorescent proteins. In general, QDs are more stable under UV light, their emission peaks are narrow, symmetric, and size-dependent, and different sized QDs can exhibit different colors under a single excitation light [3] [4] [5] . Among the typical QDs, CdSe, and CdTe species possess the best luminescent properties, but Cd-related compounds are harmful to both human health and the environment [6] . Therefore, in the past decade, researchers have made efforts to find candidates with low toxicity, such as dye-doped nanoparticles (NPs) [7] , carbon dots [8] , metal nanoclusters [9, 10] , upconversion luminescent NPs [11] , and ZnO QDs [12] .
ZnO is one of the most excellent semiconductors, with great potential for replacing the traditional Cd-related species applied in the optical and biological fields. To date, various ZnO nanostructures have been reported, including NPs, nanorods (NRs), nanotubes, nanorings, and nanoflowers. The corresponding synthetic methods, such as the sol-gel method and chemical vapor deposition have been developed, which impact the physical properties of the obtained ZnO products. For instance, the sol-gel route can produce numerous defects on the surface of the ZnO NPs, and the NPs show strong visible emission. Since the defect-related luminescence of ZnO NPs is easily destroyed by water molecules, appropriate surface modifications are required to stabilize ZnO luminescence. The luminescent ZnO NPs (also called ZnO QDs) have good photophysical properties, and their surfaces can be modified conveniently. After careful modification, ZnO NPs are very stable in aqueous solution [13] and their quantum yield (QY) can be improved to about 30% (even to 85%) [14] ; their emission color can be tuned from blue to yellow [15] . Since ZnO is considered to be a safe matter generally, it has been widely used as a food additive [16] , in food packaging [17] , and in sunscreen products [18] . Hence, luminescent ZnO NPs, as one of the novel types of low-cost, low-toxicity, and biocompatible nanomaterials, are expected to perform better in biological applications.
In this review, we will summarize the synthetic strategies and functionalization routes for the luminescent ZnO NPs, and their applications in the detection of various analytes, as well as in biological imaging, antibacterial activity, and drug delivery. In the final section, we will discuss the challenges concerning ZnO NPs that researchers are facing currently.
Preparation and Functionalization of Luminescent ZnO NPs

Luminescent Mechanisms of ZnO NPs
Various luminescent mechanisms of ZnO NPs have been suggested, as shown in Table 1 . Although these mechanisms are controversial and not clear so far, a widely accepted model is composed of two bands (Figure 1) , with UV emission arising from the typical band gap transition and visible emission due to the ZnO defects. The ZnO band gap is 3.37 eV at room temperature, so that the typical UV emission is ascribed to direct exciton transition, which means the excited electron recombination with holes in the valence band (VB) or in traps near the VB produces UV emission of around 370 nm. For the visible emission, many point defects have been suggested, including oxygen vacancies, oxygen interstitials, antisite oxygen, zinc vacancies, zinc interstitials, and surface states [19] . Up to now, two popular mechanisms for this visible emission are still in debate, as discussed in our previous review [20] : one is recombination of an electron from the conduction band (CB) with a hole in a deep trap [21] , and the other is recombination of holes from the VB with a deeply trapped electron [22] . Note: Ultraviolet (UV); dodecylamine (DDA); poly(vinylpyrrolidone) (PVP); polymethylacrylic acid (PMMA); polystyrene (PS); Nanorods (NRs).
Synthesis of Luminescent ZnO NPs
The main synthetic methods of luminescent ZnO NPs can be divided into two categories based on the luminescent mechanisms mentioned above. For the highly crystallized and purified ZnO nanostructures which show strong UV emission in general [39] , pyrolysis, chemical vapor deposition, and molecular beam epitaxial growth at high temperature are usually employed [40] . For example, UV emitting ZnO QDs were recently fabricated for the first time by magnetron sputtering at room temperature [35] . In contrast, ZnO visible emission intensity is closely related to the defect concentration, so that the sol-gel technique and sonochemical synthesis at room temperature are usually employed to produce ZnO NPs with highly visible emission [41] . 
Functionalization of Luminescent ZnO NPs
The functionalization of ZnO NPs has three purposes. One is to stabilize ZnO NPs, especially in aqueous solution, because stability towards water is strictly necessary for biological applications. Another is to graft specific functional groups onto ZnO surface for targeted analyses. The third is to change or enhance ZnO luminescent properties.
In order to stabilize ZnO NPs, various shells have been employed, such as silica [34] , zinc sulfide [42] , organic ligands [29, 43] , and polymer [30] . These shells are able to prevent the NPs from spontaneous growth and aggregation, and reduce the damage to the luminescent centers by aqueous solution. It should be noted that water can exchange those unstable ligands on the ZnO NPs' surface so as to destroy the luminescent centers [44] . There are at least three factors which should be considered carefully when the ZnO NPs are applied to biological media: (1) the employed protect shell should be biocompatible to the tissues and cells; (2) the luminescence emission of ZnO NPs should not be covered by the autofluorescence of the biological background; and (3) the luminescence of ZnO NPs should not be quenched by surface modification. To overcome these difficulties, our group proposed a two-step copolymerization route for the preparation of core-shell ZnO NPs with stable luminescence in aqueous solution [45] . The polymer shell contains a hydrophobic internal layer and an external hydrophilic layer, which protects the ZnO cores and makes the NPs water dispersible, respectively.
As for the specific functionalization, silane-based polymers [46, 47] and hyperbranched polymers [48] were employed frequently. On the one hand, the silica or hydrophobic ligands protect the ZnO luminescent centers. On the other, the polymer dendrons or hydrophilic shells not only render good solubility in water, but also provide terminal groups like amines, carboxylic acids, and thiols for grafting specific groups by conjugation chemical reactions. For instance, 3-[2-(aminoethyl) aminopropyl] trimethoxysilane can be used for post surface modification of silica coated ZnO NPs by introducing amino groups [49] , and then conjugating with bioactive molecules for biometrics. Doping metal ions into ZnO NPs is an effective method to modify ZnO luminescence. In our previous research, Mg 2+ was doped into the lattice of ZnO NPs and the luminescence was adjusted from blue to yellow with highly improved efficiency [50] [53, 54] .
Luminescence Sensors Based on ZnO NPs
Detection of Metal Ions
As shown in Table 2 [55] found this novel, turn-off luminescent assay for Cu 2+ ions had highly repeatable and reliable performances, and the limit of detection (LOD) was measured to be 7.68 × 10 ions with the core-shell NPs, so a highly selective sensor was needed to detect Cu 
Detection of Organic Molecules
Dopamine (DA), as one the of significant catecholamine neurotransmitters and derived from the amino acid tyrosine, plays a crucial role in normal homeostasis and clinical diagnosis. The abnormal content of DA may result in several diseases and neurological disorders, such as schizophrenia, Parkinson's, and Alzheimer's diseases [64] . A simple luminescence method for DA detection has been developed based on (3-aminopropyl) triethoxysilane (APTES) capped luminescent ZnO NPs [57] . The luminescence of ZnO NPs can be quenched by DA with high selectivity and sensitivity, and the relative luminescence intensity was linearly proportional to the concentration of DA within the range 5 × 10 M. The sensing mechanism was suggested to be due to the luminescence quenching effect caused by the electron transfer from ZnO NPs to oxidized dopamine-quinone. 2,4,6-trinitrophenol (picric acid, PA) is one of the most toxic compounds, and it can cause anemia, headache, and liver injury. Singh et al. [58] synthesized water stable APTES capped ZnO NPs which can be quenched by PA with high selectivity and sensitivity (LOD = 2.86 × 10
M). The quenching mechanism could be attributed to the PA binding on the surface of APTES capped ZnO NPs, which traps the excited electron by electron transfer mechanism.
Unlike the above-mentioned luminescence turn-off detection mode, Zhao et al. [59] introduced a novel luminescence turn-on assay for phosphate. Before detection, the amine-zinc interactions and electrostatic interactions between the negatively charged metal-organic frameworks and the positively charged ZnO NPs resulted in the luminescence quenching of ZnO NPs, along with the formation of a flower-like complex. After introducing phosphate ions into the complex system, the burst of phosphate ions could inhibit the quenching effects, and recover the luminescence of ZnO NPs. The present luminescent sensing strategy exhibits good sensitivity in the range of 5 × 10 
M.
Jana et al. [60] reported another strategy to control photostability of silane modified ZnO NPs for selective detection of aldehyde groups which commonly exist in biomolecules and bio-intermediates. The aldehyde groups could form imine with the amino-functionalized ZnO NPs, leading to luminescence quenching of ZnO NPs under UV light. ZnO luminescence was reduced by 54% and 71% from the maximum intensity after 10 min of UV exposure, when the o-phthalaldehyde (OPA) concentrations are 5 × 10 M, respectively. In contrast, only 29% reduction from the maximum luminescence intensity of ZnO NPs was observed after 10 min of UV exposure without OPA.
As a new technique, a fluorescence-linked immunoassay (FLISA) based on luminescent Cd-doped ZnO NPs was utilized for the determination of bisphenol A (BPA) [61] . The BPA antibodies were coupled to the water-soluble luminescent Cd-doped ZnO NPs, then they were employed to FLISA analysis. Furthermore, this immunosensing is based on a competitive luminescence signal change due to the 4,4-bis (4-hydroxyphenol) valeric acid (BVA), which is also an antigen like BPA. When the concentrations of BVA and ZnO NPs labeled antibodies were fixed values, respectively, the BVA was coated at a substrate, and then the different concentrations of BPA and fixed concentrations of ZnO NPs labeled antibodies were added to the substrate. BPA enabled competitive reaction in order to reduce the reaction between BVA and antibodies, and finally, different luminescence signals could be in this work.
Detection of Proteins
Conjugation of selective receptor molecules such as antibodies and aptamers to the surface of luminescent ZnO NPs has been employed for detection of proteins. Gu et al. [62] reported that they developed a sandwich-type sensitive immunoassay to detect carbohydrate antigen 19-9 (CA 19-9), by using ZnO NPs as both electrochemical and luminescent labels. CA 19-9 is a preferred label for pancreatic cancer, which is a highly lethiferous sarcomata and difficult to be diagnosed early in current clinical medicine. Through the immunoreaction of ZnO labeled CA 19-9 antibodies and antigens, the immunological recognition of CA 19-9 was by detection of the amplified signals of an intrinsic luminescence of the labeled ZnO or by the square wave stripping voltammetry. The luminescent method had a detection range of 1-180 U·mL 
Biological Imaging by ZnO NPs
Fluorescence Biological Imaging
Semiconductor QDs were used for the first time for biological imaging in 1998, and this opened a prelude to the biological applications of QDs [65, 66] . However, the traditional QDs, like CdSe and CdTe, have encountered potential safety concerns in vivo [67] . Luminescent ZnO NPs, due to their special advantages, such as bright emission, low cost, and good biocompatibility, were reported to be a better candidate in biological applications [68, 69] , as we summarized in Table 3 . For example, we prepared stable luminescent ZnO NPs and applied them to cell imaging successfully for the first time in 2008 [45] . Later, the luminescent ZnO NPs were injected into mice, and exhibited visible emission on the mice skin under UV light [70] .
Despite these advances in bioimaging applications, there are still challenges in front of us. First, the luminescent ZnO NPs have a relatively broad emission band, resulting in the overlap of their fluorescence spectra with the biological autofluorescence [3] . Secondly, since the ZnO bandgap (3.37 eV at room temperature) locates in the UV region, UV light is necessary to excite ZnO luminescence, and most bioimaging applications in the literature are based on single photon UV excitation [27] . However, UV light is not suitable for deep tissue imaging in vivo due to the reduced penetration depth, absorption, and scattering of optical signals, and, in fact, it can only penetrate the animal skin by several millimeters. In addition, UV light is harmful to cells, tissues, and live animals [71, 72] . Therefore, multi-photon or fluorescence lifetime imaging may be solutions to the above problems. Note: second harmonic generation (SHG); sum frequency generation (SFG); four wave mixing (FWM).
Multiphoton Biological Imaging
Two-photon imaging or multiphoton imaging has advantages in the deeper imaging inside tissues and the reduced photo-toxicity of NIR light. A two-photon process occurs when a molecule is excited by absorbing two photons simultaneously, as shown in Figure 2 . Two-photon excitation or multiphoton fluorescence imaging using NIR excitation allows ZnO NPs to overcome the bottleneck of high energy UV excitation wavelengths. Unfortunately, the directly two-photo excited luminescence from ZnO NPs has not succeeded yet, especially in biological imaging, because an efficient two-photon excited luminescence is correlated with two-photon resonance and limited to specific wavelengths [83] . Interestingly, ZnO NPs exhibit non-linear properties which give us another choice. Second harmonic generation (SHG) is not a fluorescence process such as usually occurs in combination with two-photon excited fluorescence. Unlike fluorescence involving fluorescence radiation from an excited state, SHG occurs when two photons interact with an asymmetric material in a scattering process to generate a single photon at twice the energy (i.e., at half the excitation wavelength) [84] , as shown in Figure 2 . Since it does not have excited state, SHG is an ultrafast optical process with virtually no measurable lifetime. The common nonlinear materials, including the biologically significant molecule collagen, and certain membrane-bound dyes, or specially designed nonlinear molecular probes, have been reported [85] . The ratio of SHG to autofluorescence intensity in mammalian skin has been used as an indicator of skin ageing [86] . In previous reports, SHG imaging provides plenty of advantages [84, 87, 88] : (1) SHG is an inherent signal and does not need the external dyes; (2) the imaging signal and background are better than single photon UV excited autofluorescence imaging; (3) nonlinear excitation allows three-dimensional (3D) resolution in vivo; (4) due to the fact that SHG is a nonresonance nonlinear process, it does not require conventional phase matching compared with the traditional two-photon bioimaging; (5) SHG does not hurt cells and tissues owing to its nonradiative decay pathway; and (6) SHG emission wavelength can be inter changed with the excitation wavelength, allowing spectral separation between signals from the targeted molecule and other autofluorescence molecules by a proper choice of the excitation wavelength.
ZnO NPs have a noncentrosymmetric structure, so they can be used as nonresonant nonlinear optical probes for bioimaging applications by the SHG technique. As shown in Figure 3 , the SHG emission spectra from the ZnO NPs can be observed with tunable wavelengths of the incident laser [89] , and the SHG efficiency is unaffected by the dispersion of ZnO NPs in water [80] . The SHG signal from ZnO NPs is spectrally well-defined and is dependent on the full-width at half maxima of the incident laser pulse. These results exhibit four advantages of ZnO NPs for SHG imaging: (1) this spectral width is significantly narrower than full-width at half maxima of molecular dyes, fluorescent proteins, or traditional QDs; (2) the intensity variation is induced by the change in the input intensities and the change in the grating efficiency; (3) the SHG signal does not blink or photobleach like most of the fluorescent QDs, and is observed to be stable over several hours of illumination [90] ; and (4) it can effectively avoid the interference of autofluorescence by choosing the appropriate excitation laser source.
In a biological system, e.g., in skin, the autofluorescence on excitation in the range of 340~380 nm are mostly attributed to nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide phosphate (NAD [P] H), flavin adenine dinucleotide (FAD), and porphyrins, which provide about 75%, 25%, and 2%, with center wavelengths at 450 nm, 520 nm, and 625 nm, respectively [91] . Zvyagin et al. [78] found that the emission of ZnO NPs could be separated from the autofluorescence in skin using an appropriate spectral band. Figure 4 shows the in vivo images of human skin treated by the ZnO NPs. Overlaid multiphoton images of human skin in vivo and ZnO distribution, 4 h after its topical treatment, are colored green and red for human skin and ZnO NPs, respectively. The signals from ZnO can be clearly observed on the skin autofluorescence background, especially pronounced on the top-most layers of the skin, and the ZnO NPs' localization in the skin folds and dermatoglyph (14~30 μm). The result confirmed the potential prospect of ZnO NPs for deep imaging inside tissues by using SHG. 
Fluorescence Lifetime Imaging
Fluorescence lifetime imaging (FLIM) is another useful biological imaging technique, which is based on measuring the lifetime of the fluorescent molecule which is used to stain the biological sample, and it can be measured in any phase: gas, liquid, solid, or any combination of these phases [85] . As shown in Tables 4 and 5 , compared with the lifetime of the autofluorescence background from cells and tissues, ZnO QDs have an alterable luminescence lifetime after excitation, and this could be an advantage for time-gated imaging, as long as the appropriate spectral emission bands and synthesis methods are used. In general, the exciton emission has a short lifetime, while the defect related emission shows a long lifetime. In an attempt to investigate the FLIM for ZnO NPs, first of all, the appropriate experimental condition should be selected to avoid overlapping with the autofluorescence. Roberts et al. [86] found that the shorter fluorescence lifetime for ZnO nanomaterials considerably overlapped with that of the dominant NAD (P) H autofluorescence. However, the separation is applicable with longer lifetime measured by a pulse laser. Note: two-photon excitation (2P).
ZnO NPs have been employed to fluorescence lifetime imaging in human skin [82] , as shown in Figure 5 . The skin was treated with ZnO NPs for 4 h, then the skin was visualized with multiphoton imaging at different depths below the skin surface, as was the untreated skin. At 10 μm from the surface of human skin, an additional peak at 270 ps can be observed in the treated sample but cannot be seen in the control (Figure 5a,b) . This peak represents the short lifetime of ZnO NPs as the dark blue region in the false colored image. At 31 μm depth, there is a peak at about 3000 ps apparent in the treated skin but not in the control (Figure 5c,d) . However, no signals from ZnO are found in the treated skin at 45 μm depth. This research confirmed ZnO FLIM for human skin can reach several tens of micrometers in depth. 
Antibacterial Activity of ZnO NPs
ZnO is currently listed as a generally recognized safe material by the US Food and Drug Administration (21CFR182.8991) [106] . Yang et al. [107] recently investigated the toxicity and biodistribution of aqueous ZnO QDs in mice, and the results showed that no haemolysis occurred even at a high concentration of 1600 μg·mL −1 in vitro haemolytic assay, which demonstrated that the QDs-PEG (polyethylene glycol, PEG) displayed good blood compatibility. However, ZnO NPs exhibit antibacterial properties against a range of both gram-positive and gram-negative bacteria through a cytotoxic mechanism, and have attracted heightened research interest, as shown in Table 6 . It has been suggested that the mechanism by which ZnO NPs demonstrate antibacterial activity may involve the accumulation of NPs in the outer membrane or cytoplasm of bacterial cells [108] , and may be attributed to the excess reactive oxygen species (ROS) [109] and the release of Zn 2+ [110, 111] , as shown in Figure 6 . ROS are generated from activated ZnO NPs and usually in the light, which include superoxide (O2-), hydroxyl radical (-OH), and hydrogen peroxide (H2O2). Compared with O2-and -OH, H2O2 is often considered the main harmful factor, because it can penetrate the bacteria easily due to relatively weaker electrostatic interaction between ions and bacteria [112] . For the cytotoxic of Zn 2+ , Applerot et al. [113] reported that no significant effects on the viable count of E. coli or S. aureus were observed even when 25 mg·L
was employed in the experiment. In contrast, Bellanger et al. [110] reported that ZnO QDs and ZnCl2 were more toxic towards E. coli MG1655 and C. metallidurans CH34, and the IC50 for E. coli MG1655 were 1.6 × 10 M for ZnCl2 and ZnO QDs, respectively. And thus the toxicity is mainly from Zn 2+ . We think there are two factors, at least, related to the conflicting conclusion of Zn 2+ ion toxicity: one is that the different bacteria has different intrinsic, the other is that Zn 2+ is a nutrient for the bacteria when it is in a lower concentration, but is antibacterial at high concentrations. So the suitable Zn 2+ concentrations are different when different biological systems are studied. The antimicrobial activity of the ZnO NPs was reported to have a size dependency, i.e., decreasing ZnO NP sizes resulted in the greater antimicrobial activity [113] . The antibacterial activity of ZnO was attributed to reactions between ZnO surface and water, and the aqueous ZnO NPs suspensions were able to produce high levels of ROS. Compared with the larger ZnO NPs, the smaller ones have both higher surface areas and larger numbers to cover target bacteria. The acetate modified ZnO QDs (3~5 nm) and nitrate modified ZnO QDs (4~7 nm) displayed great antibacterial activity against E. coli [115] , and the differences between these two kinds of ZnO QDs suggested that the surface groups on ZnO QDs played important roles. Therefore, appropriate surface modifications are helpful to enhance the ZnO antibacterial activity, such as crystal violet-coated ZnO encapsulated silicone polymers [118] , Ag-ZnO nanocomposite [117] , and CdO-ZnO nanocomposite [119] . Adams et al. [114] reported that when E. coli DH5α and B. subtilis CB310 were treated with the similar ZnO nanomaterials, respectively, different antibacterial activities were found. This result revealed that the tolerance and surface charge of bacteria are also important factors for the ZnO antibacterial activity [120] .
Drug Delivery by ZnO NPs
Cancer is a serious threat to human health, and it is the second leading cause of death in the USA accounting for about 25% of all deaths [121] . However, current anticancer chemotherapies often show toxic adverse effects and low efficacy due to the failure to differentiate between cancerous and normal cells by the drug itself, as well as the development of drug resistance. Drug delivery systems (DDSs) based on nanotechnology exhibit great potential in anticancer treatment and have been employed to deliver anticancer drugs to the target tissues. Considering the extracellular mildly acidic environment in the solid tumor tissues and the intracellular compartments such as endosomes and lysosomes [122, 123] , NPs were designed to enter cells through the cellular endocytic pathway and fuse with lysosomes [124] , so that a pH-responsive DDS will be an ideal choice for cancer therapy. Fortunately, ZnO NPs can exhibit great stability in physiological condition (pH 7.4), but rapidly dissolve at pH 5~6. As shown in Table 7 , a number of DDSs based on ZnO nanomaterials have been investigated and the results display their good pH-responsive profiles. ZnO NPs were used as cappers to cover the pores of mesoporous silica NPs (MSNs), and when these DDS met with acids, the ZnO NPs decomposed to release doxorubicin (DOX) molecules from MSNs [125] . However, this type of DDS has difficulty in degradation so that it cannot completely release the drugs [126, 127] . Another strategy is based on loading drugs onto the simple ZnO NPs directly, and thus, when the composites meet acid the ZnO NPs decompose completely to release all the drug molecules [128] . The corresponding drug delivery mechanisms are in Figure 7 . Although the stabilized ZnO NPs revealed good biocompability and low toxicity, after ZnO decomposition, Zn 2+ ions are cytotoxic [129] , so they were used directly for cancer treatment [130] or enhancing the DDS toxicity. Additionally, the ZnO NPs can produce destructive ROS, as mentioned previously in their antibacterial activity. They will be able to destroy the cancer cells directly as well, or enhance the cytotoxic effect of DDS under appropriate light. Kishwar et al. [131, 132] recently investigated the phototoxic effect of ZnO NRs on human cells. They demonstrated that the ZnO NRs coated with drugs could exhibit the enhanced cytotoxic effect under UV irradiation as a result of the production of ROS. The photodynamic therapy (PDT) will be helpful for the tumor treatment because it can be restricted to trigger at the tumor location. Note: poly (2-(dimethylamino) ethyl methacrylate) (PMAA-co-PDMAEMA); poly (N-isopropylacrylamide) (PNIPAM); polyethylene glycol (PEG); O-carboxymethyl chitosan (O-CMCS); upconverting nanoparticles (UCNPs); doxorubicin hydrochloride (DOX); Protoporphyrin dimethyl ester (PPDME); deoxyribonucleic acid (DNA). 5-aminolevulinic acid (ALA).
Despite DOX molecule being used as the drug in most DDS, other medicines such as toxin protein [145] , short interfering RNA (SiRNA) [146] , and deoxyribonucleic acid (DNA) [142] , also have great potential in treatment of diseases. Zhang et al. [73] reported ZnO QDs as carriers for plasmid DNA delivery, such polycation-modified ZnO QDs-DNA nanocomplex which could mediate an efficient transfer of plasmid DNA into COS-7 cells. After the ZnO nanomaterials are dissolved in the acid condition in cells, the released Zn 2+ may induce a series of harmful cellular outcomes, such as lysosomal damage, mitochondrial perturbation, ROS production, excitation of pro-inflammatory cytokine, and chemokine production [111] . Therefore, how to choose the drug and how to optimize ZnO carriers for selective destruction of tumor cells and tissues has become an urgent demand. PDT can induce nonspecific tissue and cell damage because it can be selectively illuminated at the tumor tissue. However, ZnO-related PDT DDSs were mostly based on UV irradiation, and UV light is not an ideal choice for using deep PDT in cancer treatment. Furthermore, most of the present researches are limited in the cellular level, and the evaluation of ZnO-drug nanocaomposites in live animals is still scarce. 
Conclusions
In this review, the luminescent properties and biological applications of luminescent ZnO NPs have been summarized and discussed, including the luminescent mechanisms, synthesis methods, functionalized strategies, luminescent sensors, biological imaging, antibacterial activity, and drug delivery. ZnO NPs, as a kind of low-cost, low-toxic, and versatile material, have shown to have a promising future in biological applications. However, there are still challenges in front of researchers. First, the luminescent mechanisms of ZnO NPs need more deep interpretation, because many synthesis and modification routes are apt to quench ZnO fluorescence and only a few methods are able to improve or change ZnO fluorescence effectively. Secondly, ZnO bioimaging on the multiple target cells and live animals has not succeeded yet. Nonlinear fluorescence imaging and fluorescence lifetime by using ZnO NPs are investigated scarcely, and the influence factors are not fully clear. Thirdly, both antibacterial and anticancer performances of ZnO NPs have shown a bright future, but they all require plenty of work before any practical applications.
